We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
AngioDynamics
ANGO
$570M
| $310K | ﹤0.01% |
+15,701
| New | +$320K |
|
1177
Ardmore Shipping
ASC
$669M
| $308K | ﹤0.01% |
+37,747
| New | +$263K |
|
1178
Veeva Systems
VEEV
$32B
| $307K | ﹤0.01% |
+1,896
| New | +$276K |
|
1179
Vicor
VICR
$9.17B
| $306K | ﹤0.01% |
+9,842
| New | +$316K |
|
1180
Red Robin
RRGB
$135M
| $304K | ﹤0.01% |
+9,937
| New | +$305K |
|
1181
CVB Financial
CVBF
$3.99B
| $300K | ﹤0.01% |
14,263
-25,919
| -65% | -$552K |
|
1182
iShares Mortgage Real Estate ETF
REM
$543M
| $299K | ﹤0.01% |
7,085
-2,500
| -26% | -$107K |
|
|
HMLP
1183
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $299K | ﹤0.01% |
+17,293
| New | +$320K |
|
1184
Q32 Bio
QTTB
$452M
| $298K | ﹤0.01% |
847
+699
| +472% | +$275K |
|
|
LBC
1185
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $296K | ﹤0.01% |
+27,214
| New | +$284K |
|
|
ADSW
1186
DELISTED
Advanced Disposal Services Inc
ADSW
| $296K | ﹤0.01% |
+9,281
| New | +$292K |
|
1187
VanEck Oil Services ETF
OIH
$2.07B
| $289K | ﹤0.01% |
975
-816
| -46% | -$254K |
|
1188
Allison Transmission
ALSN
$9.99B
| $288K | ﹤0.01% |
6,221
+3,863
| +164% | +$175K |
|
1189
UMB Financial
UMBF
$10.7B
| $284K | ﹤0.01% |
+4,322
| New | +$285K |
|
1190
CryoPort
CYRX
$760M
| $282K | ﹤0.01% |
+15,468
| New | +$245K |
|
1191
Ultralife
ULBI
$91.4M
| $278K | ﹤0.01% |
34,959
-18,600
| -35% | -$169K |
|
1192
Seaboard Corp
SEB
$4.5B
| $277K | ﹤0.01% |
+67
| New | +$287K |
|
|
CMD
1193
DELISTED
Cantel Medical Corporation
CMD
| $276K | ﹤0.01% |
3,418
+2,057
| +151% | +$145K |
|
|
BPT
1194
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $275K | ﹤0.01% |
+17,765
| New | +$350K |
|
1195
Automatic Data Processing
ADP
$103B
| $271K | ﹤0.01% |
+1,637
| New | +$266K |
|
1196
Marten Transport
MRTN
$1.26B
| $270K | ﹤0.01% |
+22,320
| New | +$279K |
|
1197
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
| $267K | ﹤0.01% |
+8,080
| New | +$265K |
|
|
INST
1198
DELISTED
Instructure, Inc.
INST
| $267K | ﹤0.01% |
+6,290
| New | +$272K |
|
|
EVA
1199
DELISTED
Enviva Inc.
EVA
| $262K | ﹤0.01% |
+8,363
| New | +$265K |
|
|
CURO
1200
DELISTED
CURO Group Holdings Corp.
CURO
| $262K | ﹤0.01% |
+23,701
| New | +$253K |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.